Elamipretide

Elamipretide, sold under the brand name Forzinity, is a medication used for the treatment of Barth syndrome.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Elamipretide, sold under the brand name Forzinity, is a medication used for the treatment of Barth syndrome. Elamipretide is a mitochondrial cardiolipin binder. It is used as the hydrochloride salt.

It is given by injection under the skin (subcutaneous). The most common side effects identified in clinical trials include mild-to-moderate injection site reactions. Elamipretide was approved for medical use in the United States in September 2025.

The US Food and Drug Administration considers it to be a first-in-class medication.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1365399842 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

5 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.